[Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban]. [electronic resource]
Producer: 20150709Description: 183-94 p. digitalISSN:- 2214-8116
- Acute Coronary Syndrome -- drug therapy
- Administration, Oral
- Anticoagulants -- pharmacology
- Benzamides -- pharmacology
- Blood Coagulation -- drug effects
- Embolism -- prevention & control
- Factor Xa Inhibitors -- adverse effects
- Hemorrhage -- chemically induced
- Hemostatics -- therapeutic use
- Humans
- Morpholines -- pharmacology
- Postoperative Complications -- prevention & control
- Pyrazoles -- pharmacology
- Pyridines -- pharmacology
- Pyridones -- pharmacology
- Rivaroxaban
- Stroke -- prevention & control
- Thiazoles -- pharmacology
- Thiophenes -- pharmacology
- Thrombophilia -- drug therapy
- Thrombosis -- prevention & control
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.